105: Radioembolization-105: Radioembolization

Video Transcription

Video Summary

In this episode of the Liver Cancer 100 series, Dr. David Kaplan, with trainee lead Allie Kao and Dr. Neema Kakabi, discusses the basics and advancements of transarterial radioembolization (TAIR) for liver cancer, focusing on Y90 radioembolization. TAIR is an advanced treatment involving embolization with radioactive materials like Yttrium-90 to target liver tumors. The process is typically performed under moderate sedation during an outpatient procedure, with a significant focus on dosimetry for effective treatment planning.<br /><br />Dr. Kakabi outlines the distinction between ablative and palliative doses and addresses potential complications like post-embolization syndrome and radiation pneumonitis. He also discusses the role of dosimetry in assessing treatment effectiveness and highlights advances in single-session Y90 treatments, which could reduce time, cost, and improve patient outcomes. Additionally, the session compares TAIR with other treatments like chemoembolization and external radiation therapy, noting that personalized patient care and multidisciplinary approaches are crucial. The discussion emphasizes the continuous progress in radioembolization techniques, aiming to improve the efficiency and effectiveness of liver cancer therapies.

Keywords

transarterial radioembolization

Y90 radioembolization

liver cancer

dosimetry

post-embolization syndrome

radiation pneumonitis

chemoembolization

multidisciplinary approaches